Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q2 FY24 results · Jul–Sep 2023
Camlin Fine Sciences reported revenue from operations of ₹405.88 crore (down 16.0% from Q2 FY23) and net loss of ₹20.83 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 405.88 | 483.25 | −16.0% | 419.60 | −3.3% |
| Other income | 1.76 | 2.88 | −38.8% | 6.37 | −72.3% |
| Total income | 407.64 | 486.12 | −16.1% | 425.97 | −4.3% |
| Profit before tax | (12.09) | 25.61 | Turned loss | 16.08 | Turned loss |
| Net profit for the period | (20.83) | 9.87 | Turned loss | 12.02 | Turned loss |
| Attributable to shareholders of the company | (19.38) | 13.02 | Turned loss | 15.55 | Turned loss |
| EPS, basic (₹) | (1.17) | 0.83 | Turned loss | 0.96 | Turned loss |
| Net margin (%) | -5.1 | 2.0 | 2.9 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 206.21 | 243.15 | −15.2% | 161.11 | +28.0% |
| Other income | 5.63 | 12.10 | −53.4% | 6.01 | −6.3% |
| Total income | 211.85 | 255.25 | −17.0% | 167.12 | +26.8% |
| Profit before tax | (0.52) | 30.69 | Turned loss | 7.26 | Turned loss |
| Net profit for the period | (1.46) | 18.68 | Turned loss | 5.78 | Turned loss |
| EPS, basic (₹) | (0.09) | 1.19 | Turned loss | 0.36 | Turned loss |
| Net margin (%) | -0.7 | 7.7 | 3.6 |
Consolidated
- Filed with BSE
- 08 Nov 2023, 12:40 IST
- Board meeting
- 06 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Nov 2023, 12:40 IST
- Board meeting
- 06 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE